Evidence map›Paper›PMID 40167850›Full record

ArticleMedical oncology (Northwood, London, England)2025

Curcumin-gold nanoshell mediated near-infrared irradiation on human ovarian cancer cell: in vitro study.

Samaneh Rokhgireh, Shahla Chaichian, Abolfazl Mehdizadeh Kashi, Bahareh Haji Ali, Kobra Tehermanesh, Marziyeh Ajdary, Setare Nasir, Vahid Pirhajati Mahabadi, Neda Eslahi

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Samaneh RokhgirehEndometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
Shahla ChaichianEndometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
Abolfazl Mehdizadeh KashiEndometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
Bahareh Haji AliDepartment of Medical Physics, Iran University of Medical Sciences, Tehran, Iran.
Kobra TehermaneshEndometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
Marziyeh AjdaryEndometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
Setare NasirEndometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.
Vahid Pirhajati MahabadiNeurosciences Research Center, Iran University of Medical Sciences, PO Box: 354-14665, Tehran, Iran. pirhajati.v@iums.ac.ir.
Neda EslahiFinetech in Medicine Research Center, Iran University of Medical Sciences, PO Box: 354-14665, Tehran, Iran. eslahidaregorgi.n@iums.ac.ir.

Funding

Iran University of Medical Sciences 19716
6 · The paper itself

Abstract

Ovarian cancer is considered a predominant female reproductive malignancy and poses a significant threat due to its 80-90% fatality rate. The typical approach involves surgery and chemotherapy, which due to problems such as drug resistance, encourage researchers to use new methods such as nanotechnology. The current study introduces a novel strategy: leveraging Curcumin-Gold Nanoshells (Cur-AuNShs) to combat chemotherapy's adverse effects and overcome drug resistance through hyperthermia mediation. Gold-based nanoparticles that absorb laser have shown the potential to target and treat cancer selectively through highly efficient light-to-heat conversion. This experimental study focused on the synthesis of AuNShs and their subsequent conjugation with Cur. The gold shell coverage on the surfaces of silica nanoparticles was examined using UV-VIS spectroscopy and transmission electron microscopy (TEM). Dynamic light scattering (DLS) and Zeta potential analysis were employed to evaluate the stability of particle size and surface charge. Human ovarian carcinoma cell lines (SKOV-3) were treated with a combination of Cur (15 μM) and AuNShs (75 μM), under the activation of near-infrared (NIR) laser irradiation at a power of 2.5 W/cm

Indexed as

Antineoplastic AgentsCurcuminGoldNanoshellsOvarian NeoplasmsApoptosisCell Line, TumorCell SurvivalFemaleHumansInfrared RaysMetal NanoparticlesAntineoplastic AgentsCurcuminGoldApoptosisCurcuminGold nanoshellsHyperthermiaOvarian cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.